Agomelatine Drug Utilisation Study in Selected European Countries: A Multinational, Observational Study to Assess Effectiveness of Risk-Minimisation Measures First published 03/02/2017 Last updated 02/07/2024 EU PAS number:EUPAS17678 Study Finalised